VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Vivos Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.13+0.00 (+2.90%)
Close on Oct 19, 2026
- Market cap
- $2.39M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
2.6%
1M of 20M shares
Institutional holders
23
3 new, 4 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
2 buys · 0 sales
Net bought $1.81M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Dawei Luo | 572,016 | 8.52% | 13G (passive) | Jul 8, 2025 |
| Michael Skaff | 514,498 | 9.90% | 13G (passive) | Dec 17, 2024 |
| Michael C. Skaff | 2,783,102 | 19.90% | 13D (active) | Jun 30, 2026 |
| SP Manager LLC | 1,342,498 | 19.90% | 13D (active) | Jun 9, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of VVOS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 85,001 | 0.42% | $38.63K | −10,542 | 0.00% |
| IHT Wealth Management, LLC | 76,736 | 0.38% | $34.88K | +35,675 | 0.00% |
| Vanguard Capital Management LLC | 60,629 | 0.30% | $27.59K | −212,700 | 0.00% |
| Commonwealth Equity Services, LLC | 42,500 | 0.21% | $19.32K | – | 0.00% |
| UBS Group AG | 39,154 | 0.19% | $17.82K | +28,108 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 38,066 | 0.19% | $18.77K | – | 0.00% |
| Centurion Wealth Management LLC | 35,684 | 0.18% | $16.22K | – | 0.00% |
| BlackRock, Inc. | 27,817 | 0.14% | $12.64K | – | 0.00% |
| State Street Corp | 24,922 | 0.12% | $11.33K | – | 0.00% |
| Sequoia Financial Advisors, LLC | 24,000 | 0.12% | $10.91K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 23,432 | 0.12% | $10.66K | −7,400 | 0.00% |
| Northern Trust Corp | 20,775 | 0.10% | $9.44K | +8,264 | 0.00% |
| Acorn Wealth Advisors, LLC | 14,776 | 0.07% | $6.72K | – | 0.00% |
| Susquehanna International Group, Llp | 10,075 | 0.05% | $4.58K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 5,211 | 0.03% | $2.37K | −2,177 | 0.00% |
| Osaic Holdings, Inc. | 1,143 | 0.01% | $516 | – | 0.00% |
| Signaturefd, LLC | 547 | 0.00% | $249 | – | 0.00% |
| Integrated Wealth Concepts LLC | 320 | 0.00% | $144 | New | 0.00% |
| Ronald Blue Trust, Inc. | 160 | 0.00% | $73 | – | 0.00% |
| Kozak & Associates, Inc. | 49 | 0.00% | $24 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 23 | 1M | 2.6% | 3 / 3 | 4 / 4 | 0M | 1M |
| Q1 2026 | 24 | 2M | 9.1% | 8 / 3 | 2 / 2 | 2M | 0M |
| Q4 2025 | 19 | 1M | 3.3% | 1 / 6 | 3 / 5 | 0M | 0M |
| Q3 2025 | 23 | 1M | 3.4% | 7 / 4 | 5 / 3 | 0M | 0M |
| Q2 2025 | 19 | 0M | 2.0% | 4 / 5 | 2 / 5 | 0M | 0M |
| Q1 2025 | 21 | 0M | 1.7% | 6 / 8 | 1 / 4 | 0M | 0M |
| Q4 2024 | 20 | 0M | 2.3% | 2 / 4 | 2 / 5 | 0M | 0M |
| Q3 2024 | 23 | 0M | 1.2% | 6 / 5 | 3 / 2 | 0M | 0M |
| Q2 2024 | 19 | 0M | 0.9% | 5 / 3 | 2 / 2 | 0M | 0M |
| Q1 2024 | 16 | 0M | 0.7% | 3 / 4 | 1 / 3 | 0M | 0M |
| Q4 2023 | 17 | 0M | 1.3% | 17 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of VVOS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 60,769 | 0.30% | $42.54K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 60,629 | 0.30% | $27.56K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 12,072 | 0.06% | $8.45K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 8,350 | 0.04% | $5.85K | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -4,300 | -0.02% | -$1.95K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ronald Kirk Huntsman | Chief Executive Officer, Director | 158,971 | 0.79% | Sep 18, 2026 |
| Bradford K. Amman | Principal Accounting Officer | 250,080 | 1.24% | Aug 26, 2026 |
| Gregg C. Johnson | Director | 3,997 | 0.02% | Sep 18, 2026 |
| Leonard J. Sokolow | Director | – | – | Sep 18, 2026 |
| Michael C. Skaff | 10% owner | 1,342,498 | 6.67% | Jul 15, 2026 |
| Investors 4 LLC V-Co | 10% owner | – | – | Jul 15, 2026 |
| Investors 3 LLC V-Co | 10% owner | 2,398,402 | 11.92% | Apr 10, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Bradford K. Amman Principal Accounting Officer | Jul 31, 2026 | Award | +250,000 | $0.41 | $102.50K | 250,080 |
| Ronald Kirk Huntsman Chief Executive Officer, Director | Jun 30, 2026 | Other | +85,910 | $0.58 | $49.83K | 85,910 |
| Investors 3 LLC V-Co 10% owner | Mar 31, 2026 | Buy | +1,044,777 | $1.34 | $1.40M | 1,044,777 |
| Investors 3 LLC V-Co 10% owner | Mar 31, 2026 | Buy | +308,848 | $1.34 | $413.86K | 1,353,625 |
| Ronald Kirk Huntsman Chief Executive Officer, Director | Jun 20, 2023 | Buy | +14,000 | $0.53 | $7.42K | 86,521 |
| Ronald Kirk Huntsman Chief Executive Officer, Director | Jun 16, 2023 | Buy | +10,000 | $0.54 | $5.40K | 67,521 |
| Ronald Kirk Huntsman Chief Executive Officer, Director | Jun 16, 2023 | Buy | +5,000 | $0.53 | $2.65K | 72,521 |
| Ronald Kirk Huntsman Chief Executive Officer, Director | Jun 15, 2023 | Buy | +21 | $0.50 | $11 | 57,521 |
| Ronald Kirk Huntsman Chief Executive Officer, Director | Jun 14, 2023 | Buy | +10,000 | $0.49 | $4.90K | 57,500 |
| Ronald Kirk Huntsman Chief Executive Officer, Director, 10% owner | Dec 23, 2022 | Buy | +20,000 | $0.50 | $10.00K | 47,500 |
| Ronald Kirk Huntsman Chief Executive Officer, Director, 10% owner | Jun 1, 2022 | Buy | +4,000 | $1.83 | $7.32K | 27,500 |
| Ronald Kirk Huntsman Chief Executive Officer, Director, 10% owner | May 31, 2022 | Buy | +8,000 | $2.03 | $16.24K | 23,500 |
| Ronald Kirk Huntsman Chief Executive Officer, Director | Sep 21, 2021 | Buy | +5,000 | $4.31 | $21.55K | 15,500 |
| Ronald Kirk Huntsman Chief Executive Officer, Director | Aug 17, 2021 | Buy | +5,000 | $3.00 | $15.00K | 10,500 |
| Bradford K. Amman Chief Financial Officer | May 25, 2021 | Buy | +1,000 | $5.29 | $5.29K | 2,000 |
| Ronald Kirk Huntsman Chief Executive Officer, Director | May 25, 2021 | Buy | +4,000 | $5.38 | $21.52K | 5,500 |
| Bradford K. Amman Chief Financial Officer | Dec 24, 2020 | Buy | +1,000 | $7.38 | $7.38K | 1,000 |
| Ronald Kirk Huntsman Chief Executive Officer, Director, 10% owner | Dec 23, 2020 | Buy | +1,000 | $7.27 | $7.27K | 1,500 |
| Ronald Kirk Huntsman Chief Executive Officer, Director, 10% owner | Dec 11, 2020 | Buy | +500 | $8.50 | $4.25K | 500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.